North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Top Key Players by 2029

North America circulating tumor cells (CTC) liquid biopsy market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 25.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,650.96 million by 2029 from USD 442.64 million in 2021. The high prevalence of chronic diseases and increasing R&D activities for its effective application is likely to be the major drivers which propel the demand of the market in the forecast period.


The liquid biopsy is a non-invasive blood test which detects circulating tumor cells and tumor DNA fragments which are released into the blood from primary tumors and metastatic sites. It is a simple and precise alternative to surgical biopsy procedure, which allows surgeon to detect cancer at a very early stage.


The circulating tumor cells are a rare sub-set of cells which function as a seed of metastases. It is found in blood of patients who have developed solid tumors. The testing of circulating tumor cells allows the detection and quantification of tumor cells in the blood of cancer patients. The various types of biological phenotypes of circulating tumor cells (CTCs) exits includes stem cell-like or mixed, mesenchymal or epithelial. These phenotypes are present in blood in a very small quantity. Due to which, their detection needs a phase of isolation-enrichment. After that, a second phase of detection.


North America circulating tumor cells (CTC) liquid biopsy market is analysed and market size information is provided by country, technology, application and end user.


Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/north-america-circulating-tumor-cells-ctc-liquid-biopsy-market


The countries covered in the North America circulating tumor cells (CTC) liquid biopsy market report are U.S., Canada and Mexico.


The U.S. is dominating the circulating tumor cells (CTC) liquid biopsy in the North American region due to rise in number of cancer patients and presence of major players in the market.


The major companies providing circulating tumor cells (CTC) liquid biopsy are Eurofins Genomics ( a subsidiary of Eurofins Scientific), MDx Health, Guardant Health, IMMUCOR, Thermo Fisher Scientific, Inc., Menarini Silicon Biosystems, QIAGEN, Exact Sciences Corporation, Myriad Genetics, Inc., LungLife AI, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc. , Natera Inc., ExoDx ( a subsidiary of Bio-Techne Corporation), Biocept, Inc., F. Hoffman-La Roche Ltd. ,FOUNDATION MEDICINE, INC., Lucence Health, Inc., Inivata Ltd, Biolidics Limited, Vortex Biosciences among others.


Other Posts:


https://pastelink.net/oqvxm9un

https://kadeum.com/blogs/56334/Breast-Implants-Accessories-Market-Revenue-Growth-by-2028

https://talkitter.com/read-blog/89456

https://midiario.com.mx/read-blog/28197

https://kyourc.com/read-blog/91256

https://www.zedlike.com/blogs/92740/Breast-Implants-Accessories-Market-Regional-Overview-by-2028

https://www.xaphyr.com/blogs/338256/Breast-Implants-Accessories-Market-Regional-Overview-by-2028

https://www.spoke.com/topics/breast-implants-accessories-market-regional-overview-by-2028-6465f49c00339477e60111f0

https://chatterchat.com/read-blog/27431

https://chandrabindu.net/read-blog/4087

https://friendsome.online/read-blog/3134

https://tannda.net/read-blog/24927

https://uchatoo.com/read-blog/19520

https://waoop.com/read-blog/71749

https://www.recentstatus.com/post/274784_breast-implants-accessories-market-profitability-by-2028-breast-implants-accesso.html

https://linkgeanie.com/health-care-products/breast-implants-accessories-market-profitability-by-2028

https://geto.space/read-blog/113668

https://afroshub.com/read-blog/31429

https://wiwonder.com/read-blog/10202

https://www.pickmemo.com/read-blog/158787

https://vherso.com/read-blog/61642

https://article-realm.com/article/Health-Fitness/44899-Breast-Implants-Accessories-Market-Profitability-by-2028.html

https://dbmrhealthcareinsights.wordpress.com/2023/05/18/anti-rickettsial-treatment-market-growth-analysis-by-2028/

https://dbmrhealthinsights.blogspot.com/2023/05/anti-rickettsial-treatment-market.html

https://www.diigo.com/item/note/9wvry/85r6?k=dca559d7ac0a9536d097323570f32f98

https://www.evernote.com/shard/s536/client/snv?isnewsnv=true&noteGuid=ce139b2e-0419-6815-d522-4a01852405ee&noteKey=rplztvm7WhQqmGopAvewZ-f4rwKCO8w5bS8pTvFNKwNoKeuaXR_2OOwFrA&sn=https%3A%2F%2Fwww.evernote.com%2Fshard%2Fs536%2Fsh%2Fce139b2e-0419-6815-d522-4a01852405ee%2Frplztvm7WhQqmGopAvewZ-f4rwKCO8w5bS8pTvFNKwNoKeuaXR_2OOwFrA&title=Anti-Rickettsial%2BTreatment%2BMarket%2BGrowth%2BAnalysis%2Bby%2B2028

https://medium.com/@michaaelj1411/2698e7ef007a

https://justpaste.it/b5e4c

https://www.pearltrees.com/michaeljdbmr/dbmr-medical/id65545783/item519312741

https://markethive.com/dbmrmedical/blog/antirickettsialtreatmentmarketgrowthanalysisby2028


About Data Bridge Market Research:


An absolute way to forecast what future holds is to comprehend the trend today!


Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.


Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.


Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

Comments

Post a Comment

Popular posts from this blog

Asia-Pacific Medical Imaging Market Innovation by 2029

With te large scale Asia-Pacific Medical Imaging Market report, businesses can think about the scene of how the market is going to act upon in the forecast years by gaining details on market definition, classifications, applications, and engagements. The report explains market analysis based on regional, local as well as global level. It analyses the key factors which leads to market growth as well as restraints of the market growth. This industry analysis report speaks about the manufacturing process, type and applications. The universal Asia-Pacific Medical Imaging marketing report performs market share assessments for the regional and country-level segments. Medical imaging refers to the techniques and processes used to make images of the human body (or parts of it) for a variety of clinical applications, including medical operations and diagnosis, as well as medical science, which includes the study of normal anatomy and function. It is a subset of biological imaging that inc...
Read more

Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Demand Analysis by 2028

The brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market is expected to witness market growth at a rate of 5.70% in the forecast period of 2021 to 2028. Data Bridge Market Research report on brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the usage of brain PET-MRI systems for preclinical imaging is escalating the growth of brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market. Positron outflow tomography (PET) is meaningfully used for neurological applications due to its bit advantages of giving high-resolution and 3-dimensional imaging of physiologic, functional and molecular targets. Major factors that are expected to boost the growth of the brain positron outflow tomography (PET)-magne...
Read more

Asia-Pacific Mobile C-Arm Equipment Market Demand Analysis by 2029

Mobile C-arm is a medical imaging device based on X-ray technology and is widely used to capture the image of the human inner body. This C-shaped device is connected to the X-ray source and X-ray detector. The device is used in numerous medical applications such as orthopaedics, traumatology, surgery, vascular surgery and cardiology which use C-arms for intraoperative imaging. It provides real time high-resolution X-ray images that helps the physician to monitor the disease or progress during the operation and making any corrections if required. Since the last few years, there has been a huge growth in digitalization and advancement in technology in the healthcare sector. The increasing use of C-arm systems in intraoperative procedures has become an essential tool in modern surgical practice. The increasing number of surgeries such as cardiovascular surgeries, orthopedic and trauma surgeries, neuro surgeries increases the need for mobile C-arm equipment platforms, which is anticip...
Read more